• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症刺激下人冠状动脉中蛋白酶激活受体-2(PAR2)和PAR4表达增加,揭示了内皮细胞对PAR2和PAR4激动剂的依赖性舒张作用。

Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists.

作者信息

Hamilton J R, Frauman A G, Cocks T M

机构信息

Department of Pharmacology, University of Melbourne, Victoria, Australia.

出版信息

Circ Res. 2001 Jul 6;89(1):92-8. doi: 10.1161/hh1301.092661.

DOI:10.1161/hh1301.092661
PMID:11440983
Abstract

Protease-activated receptor (PAR)1 and PAR2 are expressed on vascular endothelial cells and mediate endothelium-dependent relaxation in several species, and PAR4 agonists cause similar responses in rat aortas. To date, only PAR1 has been reported to mediate relaxation of human arteries despite endothelial cell expression of both PAR1 and PAR2 in these tissues. Because inflammatory stimuli increase PAR2 expression in human endothelial cells in culture, the present study investigated the effect of similar stimuli on PARs in human isolated coronary arteries (HCAs). In HCA ring segments suspended for isometric tension measurements, the selective PAR1-activating peptide, TFLLR (0.01 to 10 micromol/L), caused endothelium-dependent relaxation of precontracted preparations. Little or no change in vascular tension was elicited by either the PAR2- or PAR4-activating peptides, SLIGKV and GYPGQV, respectively (up to 100 micromol/L). Exposure of HCAs to interleukin (IL)-1alpha (1 ng/mL, 12 hours) or tumor necrosis factor-alpha (3 nmol/L, 12 hours) did not affect PAR1 expression but increased PAR2 and PAR4 mRNA levels by approximately 5- and 4-fold, respectively, as determined by quantitative polymerase chain reaction. Similar IL-1alpha treatment did not affect TFLLR-induced relaxations but revealed significant endothelium-dependent relaxations to SLIGKV (100 micromol/L, 61.4+/-6.7%) and GYPGQV (100 micromol/L, 34.8+/-6.4%). These studies are the first to demonstrate functional PAR2 and PAR4 in human arteries in situ. The selective upregulation of PAR2 and PAR4 expression and the increased vascular response in HCAs after exposure to inflammatory stimuli suggest a role for these endothelial receptors during inflammation.

摘要

蛋白酶激活受体(PAR)1和PAR2在血管内皮细胞上表达,并介导多种物种的内皮依赖性舒张,PAR4激动剂在大鼠主动脉中引起类似反应。迄今为止,尽管在这些组织中PAR1和PAR2均在内皮细胞中表达,但仅有PAR1被报道介导人类动脉的舒张。由于炎症刺激会增加培养的人内皮细胞中PAR2的表达,本研究调查了类似刺激对人离体冠状动脉(HCA)中PARs的影响。在用于等长张力测量的HCA环段中,选择性PAR1激活肽TFLLR(0.01至10 μmol/L)引起预收缩制剂的内皮依赖性舒张。PAR2激活肽SLIGKV和PAR4激活肽GYPGQV(分别高达100 μmol/L)对血管张力几乎没有影响或没有引起变化。将HCA暴露于白细胞介素(IL)-1α(1 ng/mL,12小时)或肿瘤坏死因子-α(3 nmol/L,12小时)不影响PAR1的表达,但通过定量聚合酶链反应测定,PAR2和PAR4的mRNA水平分别增加了约5倍和4倍。类似的IL-1α处理不影响TFLLR诱导的舒张,但显示出对SLIGKV(100 μmol/L,61.4±6.7%)和GYPGQV(100 μmol/L,34.8±6.4%)有显著的内皮依赖性舒张。这些研究首次证明了原位人动脉中功能性PAR2和PAR4的存在。PAR2和PAR4表达的选择性上调以及暴露于炎症刺激后HCA中血管反应的增加表明这些内皮受体在炎症过程中发挥作用。

相似文献

1
Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists.炎症刺激下人冠状动脉中蛋白酶激活受体-2(PAR2)和PAR4表达增加,揭示了内皮细胞对PAR2和PAR4激动剂的依赖性舒张作用。
Circ Res. 2001 Jul 6;89(1):92-8. doi: 10.1161/hh1301.092661.
2
Protease-activated receptor (PAR) 1 but not PAR2 or PAR4 mediates endothelium-dependent relaxation to thrombin and trypsin in human pulmonary arteries.蛋白酶激活受体(PAR)1而非PAR2或PAR4介导人肺动脉中内皮依赖性舒张反应以应对凝血酶和胰蛋白酶。
J Cardiovasc Pharmacol. 2001 Jul;38(1):108-19. doi: 10.1097/00005344-200107000-00012.
3
Distinct roles for PAR1- and PAR2-mediated vasomotor modulation in human arterial and venous conduits.PAR1和PAR2介导的血管舒缩调节在人体动静脉管道中的不同作用。
J Thromb Haemost. 2007 Jan;5(1):174-80. doi: 10.1111/j.1538-7836.2006.02265.x. Epub 2006 Oct 16.
4
Protease-activated receptor-1 (PAR1) and PAR2 but not PAR4 mediate relaxations in lower esophageal sphincter.蛋白酶激活受体-1(PAR1)和PAR2而非PAR4介导食管下括约肌的舒张。
Regul Pept. 2007 Jul 5;142(1-2):37-43. doi: 10.1016/j.regpep.2007.01.004. Epub 2007 Jan 31.
5
Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4.炎症介质通过诱导蛋白酶激活受体-4的表达来调节人支气管成纤维细胞中的凝血酶和组织蛋白酶G信号传导。
Am J Physiol Lung Cell Mol Physiol. 2007 Mar;292(3):L788-98. doi: 10.1152/ajplung.00226.2006. Epub 2006 Dec 1.
6
Enzymatic activation of endothelial protease-activated receptors is dependent on artery diameter in human and porcine isolated coronary arteries.在人和猪的离体冠状动脉中,内皮蛋白酶激活受体的酶促激活取决于动脉直径。
Br J Pharmacol. 2002 Jun;136(4):492-501. doi: 10.1038/sj.bjp.0704714.
7
Proteinase-activated receptor-1 (PAR1) and PAR2 mediate relaxation of guinea pig internal anal sphincter.蛋白酶激活受体-1(PAR1)和PAR2介导豚鼠肛门内括约肌舒张。
Regul Pept. 2014 Feb 10;189:46-50. doi: 10.1016/j.regpep.2014.03.001. Epub 2014 Mar 11.
8
Atypical protease-activated receptor mediates endothelium-dependent relaxation of human coronary arteries.非典型蛋白酶激活受体介导人冠状动脉的内皮依赖性舒张。
Circ Res. 1998 Jun 29;82(12):1306-11. doi: 10.1161/01.res.82.12.1306.
9
Cytokine upregulation of proteinase-activated-receptors 2 and 4 expression mediated by p38 MAP kinase and inhibitory kappa B kinase beta in human endothelial cells.细胞因子通过p38丝裂原活化蛋白激酶和抑制性κB激酶β介导人内皮细胞中蛋白酶激活受体2和4的表达上调。
Br J Pharmacol. 2007 Apr;150(8):1044-54. doi: 10.1038/sj.bjp.0707150. Epub 2007 Mar 5.
10
Proteinase-activated receptor 4 (PAR4): action of PAR4-activating peptides in vascular and gastric tissue and lack of cross-reactivity with PAR1 and PAR2.蛋白酶激活受体4(PAR4):PAR4激活肽在血管和胃组织中的作用以及与PAR1和PAR2无交叉反应性
Can J Physiol Pharmacol. 1999 Jun;77(6):458-64.

引用本文的文献

1
Endothelial protease-activated receptor 4: impotent or important?内皮蛋白酶激活受体4:无作用还是重要?
Front Cardiovasc Med. 2025 Jan 28;12:1541879. doi: 10.3389/fcvm.2025.1541879. eCollection 2025.
2
Protease activated receptor 2 as a novel druggable target for the treatment of metabolic dysfunction-associated fatty liver disease and cancer.蛋白酶激活受体 2 作为一种新的可药物治疗代谢功能障碍相关脂肪性肝病和癌症的靶点。
Front Immunol. 2024 Oct 11;15:1397441. doi: 10.3389/fimmu.2024.1397441. eCollection 2024.
3
Elevated protease-activated receptor 4 (PAR4) gene expression in Alzheimer's disease predicts cognitive decline.
阿尔茨海默病中蛋白酶激活受体 4 (PAR4) 基因表达升高预示认知能力下降。
Neurobiol Aging. 2024 Aug;140:93-101. doi: 10.1016/j.neurobiolaging.2024.04.007. Epub 2024 Apr 21.
4
Protease-Activated Receptors (PARs): Biology and Therapeutic Potential in Perioperative Stroke.蛋白酶激活受体(PARs):围手术期卒中的生物学特性及治疗潜力
Transl Stroke Res. 2025 Jun;16(3):933-951. doi: 10.1007/s12975-024-01233-0. Epub 2024 Feb 7.
5
PAR4 Inhibition Reduces Coronary Artery Atherosclerosis and Myocardial Fibrosis in SR-B1/LDLR Double Knockout Mice.PAR4 抑制减少了载脂蛋白 B 受体 1/低密度脂蛋白受体双重基因敲除小鼠的冠状动脉粥样硬化和心肌纤维化。
Arterioscler Thromb Vasc Biol. 2023 Nov;43(11):2165-2178. doi: 10.1161/ATVBAHA.123.319767. Epub 2023 Sep 7.
6
Activation of Human Platelets by Secreted Protease Staphopain A.分泌性蛋白酶葡萄球菌蛋白酶A对人血小板的激活作用
Pathogens. 2022 Oct 26;11(11):1237. doi: 10.3390/pathogens11111237.
7
Neurological Symptoms of COVID-19: The Zonulin Hypothesis.新型冠状病毒肺炎的神经系统症状: zonulin假说
Front Immunol. 2021 Apr 26;12:665300. doi: 10.3389/fimmu.2021.665300. eCollection 2021.
8
Punicalagin Ameliorates Lupus Nephritis via Inhibition of PAR2.鞣花酸通过抑制 PAR2 改善狼疮肾炎。
Int J Mol Sci. 2020 Jul 14;21(14):4975. doi: 10.3390/ijms21144975.
9
Using PAR4 Inhibition as an Anti-Thrombotic Approach: Why, How, and When?使用 PAR4 抑制作为抗血栓形成的方法:为什么、如何以及何时?
Int J Mol Sci. 2019 Nov 11;20(22):5629. doi: 10.3390/ijms20225629.
10
Protease-activated receptor 4 protects mice from Coxsackievirus B3 and H1N1 influenza A virus infection.蛋白酶激活受体 4 可保护小鼠免受柯萨奇病毒 B3 和 H1N1 流感病毒感染。
Cell Immunol. 2019 Oct;344:103949. doi: 10.1016/j.cellimm.2019.103949. Epub 2019 Jul 3.